IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia

BACKGROUND: The National Program for Chagas disease was implemented in Bolivia in 2006, and it greatly decreased the number of infections through vector control. Subsequently, a treatment regimen of benznidazole (BNZ) was started in seropositive school-age children living in certified vector control...

Descripción completa

Detalles Bibliográficos
Autores principales: Vásquez Velásquez, Clara, Russomando, Graciela, Espínola, Emilio E., Sanchez, Zunilda, Mochizuki, Kota, Roca, Yelin, Revollo, Jimmy, Guzman, Angelica, Quiroga, Benjamín, Rios Morgan, Susana, Vargas Ortiz, Roberto, Zambrana Ortega, Alberto, Espinoza, Eida, Nishizawa, Juan Eiki, Kamel, Mohamed Gomaa, Kikuchi, Mihoko, Mizukami, Shusaku, Na-Bangchang, Kesara, Tien Huy, Nguyen, Hirayama, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760767/
https://www.ncbi.nlm.nih.gov/pubmed/31553732
http://dx.doi.org/10.1371/journal.pntd.0007715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760767/
https://www.ncbi.nlm.nih.gov/pubmed/31553732
http://dx.doi.org/10.1371/journal.pntd.0007715

Ejemplares similares